Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Berberine is a bright yellow, plant-derived benzylisoquinoline alkaloid found in a variety of medicinal herbs (notably Coptis chinensis and Berberis species), with a characteristic tetracyclic structure. It acts as a quaternary ammonium salt and possesses a broad spectrum of observed biological activities, including anti-inflammatory, anti-diabetic, hypolipidemic, and anticancer effects. Although it affects diverse human biological targets (such as kinases, receptors, and enzymes), berberine is itself a ligand, not a target; thus, it is best classified as a multi-target natural product with pharmacological but not target properties[1][4][8][9]. Its therapeutic promise is limited by poor oral bioavailability and a paucity of rigorous clinical evidence for specific indications[2][4][7].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Berberine.